HK1150776A1 - Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms - Google Patents

Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms

Info

Publication number
HK1150776A1
HK1150776A1 HK11104926A HK11104926A HK1150776A1 HK 1150776 A1 HK1150776 A1 HK 1150776A1 HK 11104926 A HK11104926 A HK 11104926A HK 11104926 A HK11104926 A HK 11104926A HK 1150776 A1 HK1150776 A1 HK 1150776A1
Authority
HK
Hong Kong
Prior art keywords
vaginal
compositions
methods
biofilms
pathogenic
Prior art date
Application number
HK11104926A
Other languages
English (en)
Chinese (zh)
Inventor
Suzanne Gordon
Dawn Flynn
Original Assignee
Toltec Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toltec Pharmaceuticals Llc filed Critical Toltec Pharmaceuticals Llc
Publication of HK1150776A1 publication Critical patent/HK1150776A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11104926A 2007-11-30 2011-05-18 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms HK1150776A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99130807P 2007-11-30 2007-11-30
PCT/US2008/084788 WO2009070638A1 (fr) 2007-11-30 2008-11-26 Compositions et procédés pour traiter des infections vaginales et des biofilms vaginaux pathogènes

Publications (1)

Publication Number Publication Date
HK1150776A1 true HK1150776A1 (en) 2012-01-13

Family

ID=40678965

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11104926A HK1150776A1 (en) 2007-11-30 2011-05-18 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
HK15100563.0A HK1200103A1 (en) 2007-11-30 2015-01-19 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15100563.0A HK1200103A1 (en) 2007-11-30 2015-01-19 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms

Country Status (9)

Country Link
US (3) US8349368B2 (fr)
EP (3) EP2684574B1 (fr)
CN (2) CN103933063A (fr)
CA (2) CA2853152C (fr)
DK (3) DK2529723T3 (fr)
ES (3) ES2588437T3 (fr)
HK (2) HK1150776A1 (fr)
PL (3) PL2684574T3 (fr)
WO (1) WO2009070638A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CN103687604A (zh) * 2011-03-01 2014-03-26 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
BR112013032629A2 (pt) 2011-06-19 2017-08-01 Abogen Inc dispositivos, soluções e métodos para coletamento de amostra
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
ITMI20111151A1 (it) * 2011-06-24 2012-12-25 Lo Li Pharma Srl N-acetil cisteina e sua composizione per uso nel trattamento di patologie vaginali.
WO2013042140A2 (fr) * 2011-09-23 2013-03-28 Manu Chaudhary Composés non peptides et non antibiotiques pour améliorer l'innocuité et l'efficacité d'antibiotiques
CN104244942A (zh) 2012-03-19 2014-12-24 奥古斯特沃尔夫博士有限两合公司-医药 两性表面活性剂在预防和治疗阴道感染中的致病性阴道生物被膜中的应用
WO2014210156A1 (fr) 2013-06-25 2014-12-31 Mission Pharmacal Company Nouvelles formulations pour le traitement de troubles vaginaux
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
WO2016056001A1 (fr) * 2014-10-06 2016-04-14 Algamed Therapeutics (A.M.T) Ltd Compositions contenant des polysaccharides sulfatés et leurs utilisations
CN105362289B (zh) * 2015-10-24 2018-08-31 惠峪 一种阴道滞留硼酸制剂及其制备方法
WO2017173230A1 (fr) * 2016-04-01 2017-10-05 Texas State University Compositions et procédés pour la dispersion de biofilms
WO2018044967A1 (fr) * 2016-08-31 2018-03-08 Virginia Commonwealth University Administration locale de médicaments hypocholestérolémiants pour le traitement et la prévention d'une vaginose bactérienne
US12011469B2 (en) * 2017-05-23 2024-06-18 Vireo Systems, Inc. Parenteral delivery device and methods of use
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
GR1009621B (el) * 2018-07-25 2019-10-23 Ιουλια Κλεωνος Τσετη Συνθεσεις για τοπικη χρηση, που περιεχουν συνδυασμους βορικου οξεος, ελαιου τεϊοδεντρου, πανθενολης και μπισαμπολολης, χρησιμες για την αντιμετωπιση μυκητιασικων λοιμωξεων
EP4171513A1 (fr) * 2020-06-30 2023-05-03 VIREO Systems, Inc. Compositions pour lutter contre les odeurs et les démangeaisons, et procédés et dispositifs pour leur administration
WO2023201341A2 (fr) * 2022-04-15 2023-10-19 Wayne State University Compositions et procédés pour le traitement de la vaginose bactérienne

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107331A (en) * 1976-03-05 1978-08-15 Max Rosenberg Zinc chelating fungicidal composition
FR2437833A1 (fr) * 1978-10-03 1980-04-30 Rosenberg Max Traitement des affections fongiques au moyen d'agents chelatant les ions zinc
DE2946366C2 (de) * 1979-11-16 1983-12-29 Basotherm GmbH, 7950 Biberach Augentropfenflasche
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
FR2598081B1 (fr) * 1986-04-30 1990-02-02 Chauvin Blache Lab Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique
RU2058147C1 (ru) * 1991-05-17 1996-04-20 Станислав Викторович Цивинский Способ предотвращения заражения венерическими болезнями
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US5853767A (en) * 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
US6106854A (en) * 1998-03-25 2000-08-22 Belfer; William A. Disinfectant composition for infectious water and surface contaminations
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
JP2002529545A (ja) * 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液
IL146917A0 (en) * 1999-06-11 2002-08-14 Sankyo Co Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid
JP4687837B2 (ja) * 1999-09-29 2011-05-25 ライオン株式会社 眼科用組成物
DE60119337T2 (de) * 2000-06-19 2007-03-29 Santen Pharmaceutical Co., Ltd Aseptische mittel
JP2002212073A (ja) * 2001-01-15 2002-07-31 Shoei:Kk 水性液剤
CA2455504A1 (fr) * 2001-08-24 2003-03-06 Quorex Pharmaceuticals, Inc. Agents antibacteriens bases sur une liaison toxoanion
GR20010100507A (el) * 2001-11-01 2003-07-16 Μαυρουδη Γεωργιος Αναγνωσταρας Προϊον θεραπειας κολπικων λοιμωξεων
WO2003062443A2 (fr) * 2001-11-08 2003-07-31 Antex Pharma, Inc. Composes alcanes substitues et utilisations associees
US20050148570A1 (en) * 2001-11-08 2005-07-07 Liren Huang Novel substituted alkane compounds and uses thereof
WO2003084552A1 (fr) 2002-04-08 2003-10-16 Bergamon S.R.L. Composition pour le traitement local de vulvovaginite et de mycoses
CA2502148A1 (fr) * 2002-10-16 2005-02-17 Board Of Regents, The University Of Texas System Procedes et compositions pour augmenter l'efficacite de substances actives d'un point de vue biologique
WO2005055723A1 (fr) 2003-12-04 2005-06-23 The University Of Iowa Research Foundation Gallium d'inhibition de formation de films biologiques
US20050222169A1 (en) * 2004-01-16 2005-10-06 Nawaz Ahmad Compositions and methods of treating infections
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
CN1872026A (zh) * 2005-05-30 2006-12-06 张东军 阴道用新型药物制剂
US20070207095A1 (en) 2005-12-09 2007-09-06 Research Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
EP1978976A2 (fr) 2006-01-30 2008-10-15 Titan Pharmaceuticals, Inc. Utilisation du gallium pour le traitement d'infections associées aux films biologiques

Also Published As

Publication number Publication date
US20090181106A1 (en) 2009-07-16
EP2529723A2 (fr) 2012-12-05
ES2394130T3 (es) 2013-01-22
EP2227213A1 (fr) 2010-09-15
EP2684574B1 (fr) 2016-07-27
HK1200103A1 (en) 2015-07-31
WO2009070638A1 (fr) 2009-06-04
US8349368B2 (en) 2013-01-08
US20150110898A1 (en) 2015-04-23
EP2529723A3 (fr) 2013-04-03
US20130101678A1 (en) 2013-04-25
CA2853152A1 (fr) 2009-06-04
ES2588437T3 (es) 2016-11-02
US8956663B2 (en) 2015-02-17
PL2227213T3 (pl) 2013-01-31
ES2572580T3 (es) 2016-06-01
CN101951868B (zh) 2014-03-12
DK2529723T3 (en) 2016-06-13
EP2529723B1 (fr) 2016-05-11
EP2227213B1 (fr) 2012-08-29
EP2227213A4 (fr) 2011-01-05
PL2684574T3 (pl) 2017-08-31
DK2684574T3 (en) 2016-08-29
EP2684574A1 (fr) 2014-01-15
CN103933063A (zh) 2014-07-23
CA2853152C (fr) 2017-04-18
CA2706709A1 (fr) 2009-06-04
CN101951868A (zh) 2011-01-19
PL2529723T3 (pl) 2016-09-30
CA2706709C (fr) 2015-06-16
DK2227213T3 (da) 2013-01-02

Similar Documents

Publication Publication Date Title
HK1200103A1 (en) Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
HK1250936A1 (zh) 用於治療病毒感染的化合物和方法
EP2120561A4 (fr) Compositions pour traiter des biofilms, et procédés pour leur utilisation
EP2043620A4 (fr) Compositions et procédés destinés au traitement d'infections parasitaires
HK1134679A1 (zh) 用於治療感染的組合物和方法
EP2490530A4 (fr) Composés et méthodes pour le traitement d'infections bactériennes
ZA200906349B (en) Combination medicaments for treating bacterial infections
ZA201005798B (en) Treatment of microbial infections
ZA201105290B (en) Antibiotic compositions for the treatment of gram negative infections
ZA200900140B (en) Methods and compositions for treating biofilms
HK1161886A1 (en) Novel antibacterial agents for the treatment of gram positive infections
EP2316267A4 (fr) Agent antibactérien et procédé de désinfection
EP2329819A4 (fr) Composition pharmaceutique destinée à être utilisée dans le traitement des infections sexuellement transmissibles
EP2417258A4 (fr) Compositions de bactériophages pour le traitement d'infections bactériennes
EP2271328A4 (fr) Compositions antiseptiques pour le traitement d infections
ZA201202924B (en) Compositions and methods for treating bacterial infections using ceftaroline
ZA201006657B (en) Disinfection composition and process
EP2326340A4 (fr) Compositions et procédés destinés à traiter une infection par s. pneumoniae
SI2134742T1 (sl) Imunogene zmesi za zdravljenje in prepreäśevanje ĺ˝ivalskih okuĺ˝b
IL208849A0 (en) Compositions for the treatment of vaginal infections with chronic inflammation
AP2829A (en) Disinfection composition and process
EP2328611A4 (fr) Compositions et procédés destinés à traiter une infection par s. pneumoniae
GB0801768D0 (en) Treatment of microbial infections
IL211282A0 (en) Compositions and use thereof for treating s. pneumoniae infection
IL211283A0 (en) Compositions and use thereof for treating s. pneumoniae infection

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191126